| ISIN | CH0312215970 |
|---|---|
| Valor Number | 31221597 |
| Bloomberg Global ID | |
| Fund Name | PvB Alegra CLO Fund I |
| Fund Provider |
PvB Pernet von Ballmoos AG
Zürich, Switzerland Phone: +41 44 205 51 51 E-Mail: info@pvbswiss.com Web: www.pvbswiss.com |
| Fund Provider | PvB Pernet von Ballmoos AG |
| Representative in Switzerland | |
| Distributor(s) |
PvB Pernet von Ballmoos AG Zürich Phone: +41 44 205 51 51 |
| Asset Class | Other Funds |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
| Investment Strategy *** | The objective of PvB (CH) Asset-Backed Securities Fund is to achieve attractive risk-adjusted returns with low volatility and low correlation to fixed income markets. The fund invests in a broadly diversified pool of asset-backed securities and follows an absolute return strategy. |
| Peculiarities |
| Current Price * | 2,873.06 USD | 28.11.2025 |
|---|---|---|
| Previous Price * | 2,861.67 USD | 31.10.2025 |
| 52 Week High * | 2,873.06 USD | 28.11.2025 |
| 52 Week Low * | 2,224.88 USD | 29.11.2024 |
| NAV * | 2,873.06 USD | 28.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 96,318,551 | |
| Unit/Share Assets *** | 15,466,410 | |
| Trading Information SIX | ||
| YTD Performance | +26.65% |
31.12.2024 - 28.11.2025
31.12.2024 28.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | +12.06% |
31.12.2024 - 28.11.2025
31.12.2024 28.11.2025 |
| 1 month | +0.40% |
31.10.2025 - 28.11.2025
31.10.2025 28.11.2025 |
| 3 months | +0.76% |
29.08.2025 - 28.11.2025
29.08.2025 28.11.2025 |
| 6 months | +5.43% |
30.05.2025 - 28.11.2025
30.05.2025 28.11.2025 |
| 1 year | +29.13% |
29.11.2024 - 28.11.2025
29.11.2024 28.11.2025 |
| 2 years | +59.52% |
30.11.2023 - 28.11.2025
30.11.2023 28.11.2025 |
| 3 years | +96.74% |
30.11.2022 - 28.11.2025
30.11.2022 28.11.2025 |
| 5 years | +111.56% |
30.11.2020 - 28.11.2025
30.11.2020 28.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | 343.1006 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | 28.11.2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OZLM XI LTD./LLC. 7.21% | 8.65% | |
|---|---|---|
| Madison Park Funding XIX Ltd 4.57% | 8.43% | |
| OCP CLO 2015-9, Ltd./ OCP CLO 2015-9 Corp. 5.69% | 7.47% | |
| Aurium Clo IV DAC 4.52% | 6.43% | |
| Madison Park Euro Funding X DAC 4.4% | 5.38% | |
| ZAIS CLO 6 Ltd 0% | 4.77% | |
| Dryden 52 Euro Clo 2017 Designated Activity Company 0% | 4.57% | |
| OZLM XV, LTD 0% | 4.53% | |
| BNPP IP Euro CLO 2015-1 Designated Activity Company 0% | 4.53% | |
| CONTEGO CLO IV DESIGNATED ACTIVITY C 0.88% | 3.91% | |
| Last data update | 31.12.2020 | |
| TER *** | 2.82% |
|---|---|
| TER date *** | 31.12.2024 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 2.00% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |